CD44 and ovarian carcinoma: In recent studies, surface markers such as CD24 and CD44 have been used as experimental surrogates for opposite cell states in human glioblastoma (proneural/NPC-like and mesenchymal19) as well as in ovarian cancer cells (epithelial-mesenchymal20).